Increasing evidence indicates that CD34+ AML cells are less sensitive to spontaneous apoptosis and have higher levels of Bcl-2 and Bcl-xl gene and protein expression than the CD34- subpopulation [6,10-12]. Here, BCL2 is linked to acute myeloid leukemia.